Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ramunni

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 1, 1996
Human aging and the GH-IGF-I axisE Ghigo, E Arvat, L Gianotti, et al.
Journal of Endocrinological Investigation|March 1, 1997
Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in manE Arvat, B Maccagno, J Ramunni, et al.
Clinical Endocrinology|December 24, 1997
Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in manE Arvat, L Di Vito, J Ramunni, et al.
Neuroendocrinology|January 16, 1998
Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
European Journal of Endocrinology|September 1, 1995
Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humansE Arvat, L Gianotti, J Ramunni, et al.
Biological Psychiatry|March 12, 1998
Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosaL Gianotti, E Arvat, M R Valetto, et al.
Pituitary|November 18, 2000
Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's diseaseS Grottoli, E Arvat, C Gauna, et al.
European Journal of Endocrinology|November 18, 2000
Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
Pituitary|November 18, 2000
Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human agingE Arvat, G P Ceda, L Di Vito, et al.
Pituitary|June 1, 2001
Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjectsE Arvat, B Maccagno, J Ramunni, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 1, 1996
Human aging and the GH-IGF-I axisE Ghigo, E Arvat, L Gianotti, et al.
Journal of Endocrinological Investigation|March 1, 1997
Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in manE Arvat, B Maccagno, J Ramunni, et al.
Clinical Endocrinology|December 24, 1997
Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in manE Arvat, L Di Vito, J Ramunni, et al.
Neuroendocrinology|January 16, 1998
Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
European Journal of Endocrinology|September 1, 1995
Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humansE Arvat, L Gianotti, J Ramunni, et al.
Biological Psychiatry|March 12, 1998
Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosaL Gianotti, E Arvat, M R Valetto, et al.
Pituitary|November 18, 2000
Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's diseaseS Grottoli, E Arvat, C Gauna, et al.
European Journal of Endocrinology|November 18, 2000
Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
Pituitary|November 18, 2000
Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human agingE Arvat, G P Ceda, L Di Vito, et al.
Pituitary|June 1, 2001
Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjectsE Arvat, B Maccagno, J Ramunni, et al.
Pageof 5